Aortic Stenosis Clinical Trial
Official title:
Speckle Tracking Imaging in Patients With Low Ejection Fraction Aortic Stenosis (SPArKLE-AS)
In patients with aortic stenosis and low ejection fraction, how can we predict who will recover their ejection fraction after aortic valve replacement? We plan to observe 50 patients with Low EF aortic stenosis and perform serial echocardiograms pre and post-aortic valve replacement and analyze regional wall motion contractility with a new software application called speckle tracking imaging.
In patients with severe aortic stenosis and LV dysfunction, 76% of patients have an
improvement of ventricular function and NYHA class, after aortic valve replacement. The
prognostic indicators of which patients will recover EF post-operatively, has not been fully
established, but has been linked to a history of prior MI and pre-operative aortic valve
area. Furthermore it is hypothesized that those ventricles that do not recover are fibrosed,
either from prior MI or long standing LVH (hypertrophy).
Currently systolic and diastolic function will be measured pre-operatively with standard 2D
echo and Doppler. 2D Strain and Strain rate imaging with speckle tracking is a novel method
of assessing regional as well as global "contractility". This method overcomes many
limitations inherent in assessing myocardial functioning with current methodology, mainly it
is reproducible, objective, and is independent of myocardial translation, tethering and
furthermore as speckle tracking is derived from B mode images is independent of Doppler
angle.The applicability of this technology to patients with aortic valve stenosis and
systolic dysfunction and its clinical significance has not been evaluated. We hypothesize
that patients with reduced peak systolic strain rate and diastolic strain rates at baseline
adjusted for LVEF will have poorer recovery of LVEF than those with relatively preserved
strain or strain rate. As this is a pilot study, we plan to prospectively analyze 50
consecutive patients who have severe aortic stenosis and left ventricular systolic
dysfunction, EF under 40% with Speckle imaging derived strain rate imaging pre and
post-operatively for aortic valve replacement. This would be done as part of routine
pre-operative and post-operative transthoracic echocardiography using standard views, with
the exception that all studies would need to be done on the GE Vivid 7 digital ultrasound
system. Speckle derived imaging data is derived from standard B mode (Grey scale images),
with a frame rate of 50 f/s. 3 D images will also be obtained. Post-operative TTE's will be
performed before discharge and 4-12 months+/- 30 days after discharge. Baseline
characteristics will be taken from the standard pre-operative baseline study including basic
2 D valve area, EF, wall thickness and geometry, and Doppler flow data. Exclusion criteria:
Patients with prior cardiac surgery including CABG or other valve replacement, more than
mild mitral valve or aortic regurgitation and chronic kidney disease (Cr 1.5), emergent
aortic valve replacement, or endocarditis, or CAD on LHC > 50%. Informed consent will be
obtain on all patients, and they will only be included if they consent. No surgery will be
delayed for purpose of the study if the proper hardware/GE VIVID system is not available.
;
Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04310046 -
Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention - The TAVI PCI Trial
|
N/A | |
Completed |
NCT03332745 -
Mechanism of Decompensation Evaluation - Aortic Stenosis
|
||
Recruiting |
NCT06008080 -
Post-Market Clinical Follow Up Study With Navitor Valve
|
||
Recruiting |
NCT06055751 -
Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
|
||
Active, not recruiting |
NCT04815785 -
Safety and Efficacy of TaurusOne® Transcatheter Aortic Valve System in Patients With Severe Calcific Aortic Stenosis
|
N/A | |
Terminated |
NCT02202434 -
Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement
|
N/A | |
Recruiting |
NCT03029026 -
The Role of Occult Cardiac Amyloid in the Elderly With Aortic Stenosis.
|
||
Active, not recruiting |
NCT02903420 -
A Clinical Trial of Transcatheter Aortic Valves in Dialysis Patients (Japan)
|
N/A | |
Completed |
NCT02629328 -
CardioCel Tri-leaflet Repair Study
|
N/A | |
Completed |
NCT02306226 -
Symetis ACURATE Neo™ Valve Implantation SAVI TF Registry
|
||
Completed |
NCT01676727 -
ADVANCE Direct Aortic Study
|
||
Withdrawn |
NCT01648309 -
Neuropsychological Testing in Patients Undergoing Transvascular Aortic Valve Implantation
|
N/A | |
Completed |
NCT01422044 -
Risk Prediction in Aortic Stenosis
|
N/A | |
Withdrawn |
NCT00774657 -
Ventricular Remodeling In Patients With Aortic Stenosis Assessed Echocardiography
|
N/A | |
Terminated |
NCT05070130 -
OpSens PRIME CLASS
|
||
Completed |
NCT03314857 -
China XT: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population
|
N/A | |
Completed |
NCT04157920 -
Impact of Predilatation Between Self-expanding Valves
|
N/A | |
Enrolling by invitation |
NCT06212050 -
Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis
|
||
Recruiting |
NCT05893082 -
Multicenter Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
|
N/A | |
Completed |
NCT03250806 -
Early Detection of Aortic Stenosis in the Community During Flu Vaccination
|